Search for: "Genzyme Corporation"
Results 1 - 20
of 71
Sorted by Relevance
|
Sort by Date
13 Sep 2010, 5:27 am
Genzyme on Monday announced the sale of its genetics unit to Laboratory Corporation of America for $925 million in cash. [read post]
10 Nov 2010, 1:46 pm
A state statute and a 2006 proxy vote by Genzyme add an interesting twist to a hostile takeover bid by Sanofi-Aventis and help to illustrate the difficulties of making a bid for a Massachusetts corporation. [read post]
17 Apr 2007, 1:18 am
"The recent settlement with Genzyme adds further momentum to Cytochroma for achieving its corporate objectives. [read post]
23 Oct 2007, 8:03 pm
By Sherri Oslick -- Genzyme Corporation of Cambridge, MA has announced that Bioenvision, Inc. [read post]
6 May 2010, 10:04 pm
The Genzyme Corporation, facing a proxy challenge from the billionaire investor Carl C. [read post]
7 Jan 2014, 11:28 am
A Massachusetts-based biotechnology company has agreed to pay $22.28 million to resolve allegations brought by whistle-blowers in Tampa and Miami that it marketed an inappropriate use for a surgery medication, U.S. government attorneys said.Genzyme, a corporation known for its research into drugs for rare genetic diseases, is paying the settlement in a lawsuit over Seprafilm, a material it manufactures for use in the operating… [read post]
4 Mar 2015, 1:32 pm
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
26 Nov 2013, 8:56 pm
The decision concerned Genzyme Corporation's product colesevelam hydrochloride, which was the subject of an SPC. [read post]
1 Jan 2014, 8:26 am
Genzyme is a biotechnology corporation based in Cambridge, Mass., and was acquired by Sanofi-Aventis SA in April 2011 [read post]
15 Nov 2009, 4:29 pm
A federal district court has ruled in Genzyme Corp. v. [read post]
4 Sep 2015, 6:02 pm
According to DOJ’s press release: Genzyme Corporation, a wholly-owned biotechnology subsidiary of French pharmaceutical company Sanofi, agreed today to resolve criminal charges that it violated the federal Food, Drug and Cosmetic Act (FDCA) with regard to the unlawful distribution of Seprafilm, a surgical device it markets and promotes, the Justice Department announced. [read post]
9 Mar 2018, 7:30 am
One originated from the Patent Trial and Appeals Board (“Board”) (In Re Stepan Company, Aug. 25, 2017) (“In re Stepan”) and the other from a district court Genzyme Corporation v. [read post]
9 Mar 2018, 7:30 am
One originated from the Patent Trial and Appeals Board (“Board”) (In Re Stepan Company, Aug. 25, 2017) (“In re Stepan”) and the other from a district court Genzyme Corporation v. [read post]
17 Dec 2010, 2:35 am
Sprint Nextel Corporation, No. 09-cv-1387 (E.D.Va. [read post]
15 Dec 2008, 5:08 pm
Recently, two pharmaceutical companies, Genzyme Corporation and Osiris Therapeutics, announced that they have joined to develop two adult stem cell treatments. [read post]
18 Dec 2017, 5:57 pm
by Dennis Crouch My former bosses Paul Berghoff and Alison Baldwin (at MBHB) won an interesting case today on behalf of Genzyme and its corporate parent Sanofi-Aventis. [read post]
2 Dec 2009, 5:17 am
Shire’s drug has already been fast-tracked by U.S. and Canadian regulators due to the global shortage of its rival Genzyme Corporation’s alternative, Cerezyme. [...] [read post]
15 Sep 2010, 6:51 am
Food and Drug Administration in March 2010 was fast-tracked due to the shortage of Genzyme Corporation’s Gaucher drug Cerezyme. [read post]
30 Sep 2010, 8:53 am
In May 2009, Genzyme Corporation acquired the worldwide rights to a potential breakthrough treatment for Multiple Sclerosis (MS) along with three marketed oncology products from Bayer Healthcare Pharmaceuticals. [read post]
7 Aug 2009, 7:21 am
(trademark) (cable system piracy) 7/31: Genzyme Corporation v. [read post]
